Pfizer tests new pill form of heart drug
NCT ID NCT07470866
Summary
This study aims to see if a new tablet form of the drug tafamidis gets into the bloodstream the same way as the currently available capsule. It will involve 24 healthy adult volunteers who will take both forms after eating a meal. The main goal is to check if the two forms are equivalent, which is a standard step before a new version of a drug can be approved.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.